These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 23709570)
1. Cardioversion for atrial fibrillation in current European practice: results of the European Heart Rhythm Association survey. Hernández-Madrid A; Svendsen JH; Lip GY; Van Gelder IC; Dobreanu D; Blomstrom-Lundqvist C; Europace; 2013 Jun; 15(6):915-8. PubMed ID: 23709570 [TBL] [Abstract][Full Text] [Related]
2. Current strategy for treatment of patients with Wolff-Parkinson-White syndrome and asymptomatic preexcitation in Europe: European Heart Rhythm Association survey. Svendsen JH; Dagres N; Dobreanu D; Bongiorni MG; Marinskis G; Blomström-Lundqvist C; Europace; 2013 May; 15(5):750-3. PubMed ID: 23625944 [TBL] [Abstract][Full Text] [Related]
3. Contemporary approach to electrical and pharmacological cardioversion of atrial fibrillation. Rajagopalan B; Curtis AB Postgrad Med; 2012 Nov; 124(6):26-35. PubMed ID: 23322136 [TBL] [Abstract][Full Text] [Related]
4. Work-up and management of lone atrial fibrillation: results of the European Heart Rhythm Association Survey. Pison L; Hocini M; Potpara TS; Todd D; Chen J; Blomström-Lundqvist C; Europace; 2014 Oct; 16(10):1521-3. PubMed ID: 25267359 [TBL] [Abstract][Full Text] [Related]
5. Current practice for diagnosis and management of silent atrial fibrillation: results of the European Heart Rhythm Association survey. Dobreanu D; Svendsen JH; Lewalter T; Hernández-Madrid A; Lip GY; Blomström-Lundqvist C; Europace; 2013 Aug; 15(8):1223-5. PubMed ID: 23878150 [TBL] [Abstract][Full Text] [Related]
6. A prospective survey in European Society of Cardiology member countries of atrial fibrillation management: baseline results of EURObservational Research Programme Atrial Fibrillation (EORP-AF) Pilot General Registry. Lip GY; Laroche C; Dan GA; Santini M; Kalarus Z; Rasmussen LH; Oliveira MM; Mairesse G; Crijns HJ; Simantirakis E; Atar D; Kirchhof P; Vardas P; Tavazzi L; Maggioni AP Europace; 2014 Mar; 16(3):308-19. PubMed ID: 24351881 [TBL] [Abstract][Full Text] [Related]
7. Current practice of antiarrhythmic drug therapy for prevention of atrial fibrillation in Europe: The European Heart Rhythm Association survey. Dagres N; Lewalter T; Lip GY; Pison L; Proclemer A; Blomström-Lundqvist C; Europace; 2013 Apr; 15(4):478-81. PubMed ID: 23530117 [TBL] [Abstract][Full Text] [Related]
8. Clinical correlates of immediate success and outcome at 1-year follow-up of real-world cardioversion of atrial fibrillation: the Euro Heart Survey. Pisters R; Nieuwlaat R; Prins MH; Le Heuzey JY; Maggioni AP; Camm AJ; Crijns HJ; Europace; 2012 May; 14(5):666-74. PubMed ID: 22223715 [TBL] [Abstract][Full Text] [Related]
9. Preference for oral anticoagulation therapy for patients with atrial fibrillation in Europe in different clinical situations: results of the European Heart Rhythm Association Survey. Larsen TB; Potpara T; Dagres N; Proclemer A; Sciarrafia E; Blomström-Lundqvist C; Europace; 2015 May; 17(5):819-24. PubMed ID: 25926476 [TBL] [Abstract][Full Text] [Related]
10. Sex-related differences in presentation, treatment, and outcome of patients with atrial fibrillation in Europe: a report from the Euro Observational Research Programme Pilot survey on Atrial Fibrillation. Lip GY; Laroche C; Boriani G; Cimaglia P; Dan GA; Santini M; Kalarus Z; Rasmussen LH; Popescu MI; Tica O; Hellum CF; Mortensen B; Tavazzi L; Maggioni AP Europace; 2015 Jan; 17(1):24-31. PubMed ID: 24957921 [TBL] [Abstract][Full Text] [Related]
11. [Electrical cardioversion for non-valvular atrial fibrillation--underestimated risk for thromboembolic complications?]. Klein HH Dtsch Med Wochenschr; 2013 Jun; 138(24):1309-11. PubMed ID: 23737116 [TBL] [Abstract][Full Text] [Related]
12. Management of atrial fibrillation in seven European countries after the publication of the 2010 ESC Guidelines on atrial fibrillation: primary results of the PREvention oF thromboemolic events--European Registry in Atrial Fibrillation (PREFER in AF). Kirchhof P; Ammentorp B; Darius H; De Caterina R; Le Heuzey JY; Schilling RJ; Schmitt J; Zamorano JL Europace; 2014 Jan; 16(1):6-14. PubMed ID: 24084680 [TBL] [Abstract][Full Text] [Related]
13. Left atrial appendage occlusion for stroke prevention in atrial fibrillation in Europe: results of the European Heart Rhythm Association survey. Lip GY; Dagres N; Proclemer A; Svendsen JH; Pison L; Blomstrom-Lundqvist C; Europace; 2013 Jan; 15(1):141-3. PubMed ID: 23233491 [TBL] [Abstract][Full Text] [Related]
14. Monitoring in the management of atrial fibrillation. Lewalter T; Morgan J; Halimi F; Lip G; Dagres N; Blomström-Lundqvist C; Europace; 2012 Apr; 14(4):591-2. PubMed ID: 22454456 [TBL] [Abstract][Full Text] [Related]
15. [Remodeling by atrial fibrillation and clinical implications for cardioversion]. Ehrlich JR; Götte A Dtsch Med Wochenschr; 2011 Oct; 136(43):2212-6. PubMed ID: 22009176 [TBL] [Abstract][Full Text] [Related]
16. Electrical and pharmacologic cardioversion for atrial fibrillation. Kim SS; Knight BP Cardiol Clin; 2009 Feb; 27(1):95-107, ix. PubMed ID: 19111767 [TBL] [Abstract][Full Text] [Related]
17. Targeted pharmacological reversal of electrical remodeling after cardioversion--rationale and design of the Flecainide Short-Long (Flec-SL) trial. Kirchhof P; Fetsch T; Hanrath P; Meinertz T; Steinbeck G; Lehmacher W; Breithardt G Am Heart J; 2005 Nov; 150(5):899. PubMed ID: 16290956 [TBL] [Abstract][Full Text] [Related]
18. Current periprocedural management of ablation for atrial fibrillation in Europe: results of the European Heart Rhythm Association survey. Chen J; Todd DM; Hocini M; Larsen TB; Bongiorni MG; Blomström-Lundqvist C; Europace; 2014 Mar; 16(3):378-81. PubMed ID: 24569891 [TBL] [Abstract][Full Text] [Related]
19. [Anticoagulation in cardioversion of atrial fibrillation. Current status and outlook for the future]. Schimpf T; Stellbrink C Med Klin (Munich); 2003 Feb; 98(2):91-5. PubMed ID: 12601533 [TBL] [Abstract][Full Text] [Related]
20. Atrial fibrillation: rate control often better than rhythm control. Prescrire Int; 2004 Apr; 13(70):64-9. PubMed ID: 15148984 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]